In the initial stages, the induction of AR-driven senescence in tumor cells may reduce tumor growth itself, followed by the cumulative effect of promoting cells towards apoptosis en route to senescence due to the combination of senescence therapy with radiotherapeutic and chemotherapeutic protocols. Here, AR is linked to neoplasm.